Amarin Corp Plcuk (AMRN) Other Non Operating Income (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Other Non Operating Income of $188000.0 for Q1 2026, down 25.69% YoY from $253000.0 in Q1 2025, and down 93.53% sequentially from $2.9 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Other Non Operating Income (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Other Non Operating Income across 17 years of filings, most recently posting $188000.0 for Q1 2026.

  • In Q1 2026, Other Non Operating Income fell 25.69% year-over-year to $188000.0; the TTM figure through Mar 2026 stood at $3.2 million (up 3668.89% YoY), while the FY2025 annual figure was $3.3 million, up 172.77% from the prior year.
  • Other Non Operating Income slipped to $188000.0 in Q1 2026, from $2.9 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for AMRN reached as high as $3.0 million in Q2 2023 and fell as low as -$2.3 million in Q2 2022.
  • The 5-year median for Other Non Operating Income is $205000.0 (2025), against an average of $352352.9.
  • The widest YoY moves for Other Non Operating Income: up 1320.45% in 2022, down 1080.63% in 2022.
  • A 5-year view of Other Non Operating Income shows it stood at $1.2 million in 2022, then sank by 182.32% to -$1.0 million in 2023, then advanced by 26.82% to -$753000.0 in 2024, then surged by 485.66% to $2.9 million in 2025, then sank by 93.53% to $188000.0 in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $188000.0, $2.9 million, and $205000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 188,000.00
Dec 31, 2025 2.90 Mn
Sep 30, 2025 205,000.00
Jun 30, 2025 -85,000.00
Mar 31, 2025 253,000.00
Dec 31, 2024 -753,000.00
Sep 30, 2024 265,000.00
Jun 30, 2024 145,000.00
Mar 31, 2024 1.55 Mn
Dec 31, 2023 -1.03 Mn
Sep 30, 2023 -575,000.00
Jun 30, 2023 3.04 Mn
Mar 31, 2023 624,000.00
Dec 31, 2022 1.25 Mn
Sep 30, 2022 511,000.00
Jun 30, 2022 -2.26 Mn
Mar 31, 2022 -246,000.00
Dec 31, 2021 88,000.00
Sep 30, 2021 -57,000.00
Jun 30, 2021 -191,000.00